
CRISPR reveals new therapeutic target for glioblastoma
Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma rely on transforming growth factor beta-activated kinase 1 (TAK1) for survival and that inhibiting this enzyme leads to the death of the cells. Furthermore, they have demonstrated that it is… Read More











